CHICAGO--(BUSINESS WIRE)--Veradigm (NASDAQ: MDRX) announced today that Veradigm Network EHR Data is now available within the OMOP CDM format. Veradigm Network EHR is a complete statistically ...
Evaluating the cost-effectiveness of genetic testing in high-risk families with confirmed germline cancer mutations. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Increasing Quality and Efficiency of the Radiotherapy Treatment Planning Process by Constructing and Implementing a Workflow-Monitoring Application We identified the prescreening information items ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results